Retinol derivatives useful for enhancing immune response

Details Retinol derivatives useful for enhancing immune response Retinol derivatives useful for enhancing immune response

1995-06-05

1999-06-01

Richter, Johann

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514110, 514529, 514557, 568824, 558 83, A61K 31045, A61K 3107, A61K 31075

Patent

active

059088680

DESCRIPTION:

BRIEF SUMMARY
BACKGROUND OF THE INVENTION

Throughout this application various publications are referenced to by arabic numerals within parenthesis. Full bibliographic citations for these references may be found at the end of the specification immediately preceding the claims. The disclosures for the publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
It has long been known that dietary restriction of vitamin A causes widespread abnormalities in tissue and organ physiology, especially in neonates. The vitamin A deficiency syndrome is characterized by generally stunted growth, keratoses of skin and eyes (1) (leading in severe cases to blindness), defective testis development (1) etc., and atrophy of central (i.e., thymus and bursa of Fabrizius) and peripheral lymphoid organs. Consequently, immune functions are severely affected. Even in mild cases of vitamin A deficiency, the immune system appears to be hyporesponsive. In a recent study in southern India (2), the authors noted in children suffering from mild vitamin A deprivation significantly higher mortality rates in common childhood diseases compared with children receiving normal dietary levels of vitamin A. Since severity but not susceptibility to infection was correlated with vitamin A deprivation, it is likely that reduced immune functions are a factor.
In the absence of retinol, lymphoblastoid cells (LCL) die within 24 to 48 hours (3). Retinol and retinaldehyde, but not retinoic acid, support the growth of LCL in serum-free medium. The same is true for activated human thymocytes. These finding may represent direct correlates to the lagging development of lymphoid organs described by Wolbach and Howe (1) and the in-vivo immune system dysfunction referred to earlier (2).
Nearly all vertebrate tissues are bathed in a constant supply of vitamin A, and the ubiquitous distribution of cellular retinol-binding protein (CRBP) with its high affinity to retinol suggests that it is inside most cells as well. Yet the general purpose of retinol, its metabolism and final destination, remain for the most part unknown, the well-studied example of specialized usage such as vision notwithstanding. Since retinal is not known to be incorporated into structural parts of cells and does not bind to one of the yet analyzed transcription factors with high enough affinity, its role is more likely to be found in its function as precursor for derivatives. Use of retinaldehyde in vision is one example, and another that of retinoic acid as a morphogen (4), important for development of limb and brain. When coupled with parallel discoveries of retinoic acid receptors (RAR) (5-7) within the larger steroid receptor superfamily (8), a sound molecular foundation is given. In this hypothesis, RARs bind to specific response elements in the promoter regions of genes. Retinoic acid in turn binds to RAR, causing activation of gene transcription. The universal principle of this genetic control has increasingly been highlighted by observations that many developmentally important genes from drosophila to man are part of the retinoic acid/steroid receptor superfamily. Moreover, for more than two dozen "orphan receptors" (8) engaged in control of the general physiology of cells, the ligands are not known and are suspected to be small lipophilic molecules.
Many mammalian tissues are dependent on a source of retinol for ordered growth and development, and this requirement is also reflected in certain cell types propagated in tissue culture systems. The tissue culture medium needs to be fortified with retinol at a concentration approximating that of serum (i.a., 10.sup.-6 M). It is widely believed that retinol serves as a precursor molecule for production of a number of cellular metabolites that are the true mediators of retinol effects. Examples are retinoic acids (RA, all-trans RA, and 9-cis-RA) that have been implicated in differentiation and gene regulation, respectively.
Lymphocytes also exh

REFERENCES:
patent: 3247239 (1966-04-01), Truscheit et al.
patent: 4268444 (1981-05-01), Jaedicke
patent: 4614747 (1986-09-01), Loev et al.
patent: 4825006 (1989-04-01), Otera et al.
patent: 5124083 (1992-06-01), Shealy
patent: 5358972 (1994-10-01), Buck et al.
patent: 5521221 (1996-05-01), Buck et al.
Synthesis of Double Bond Shifted Isomers of Vitamin A" J. Am. Chem. Soc. (1985) 107: 1028-1033.
Garbe, et al., "Retinoids are important cofactors in T cell activation", Chemical Abstracts 117: 88604t (1992).
Paust J., Recent Progress in Commercial Retinoids and Carotenoids, Pure and Applied Chemistry 63(1): 45-58 (1991).
Yamauchi, R., et al., "Peroxyl-radical Reaction of Retinyl Acetate in Solution", Bioscience, Biotechnology and Biochemistry (1992) 56(10): 1529-1532 (Exhibit 11).

Affiliated with

Also associated with

Rating

Retinol derivatives useful for enhancing immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retinol derivatives useful for enhancing immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinol derivatives useful for enhancing immune response will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-955241